#South Korea #Seoul #Cynosure #Mosaic 3D #Lutronic

Cynosure Lutronic's Mosaic 3D™ Achieves Major Milestone

Cynosure Lutronic, a prominent player in the field of energy-based medical aesthetics, has reached a significant milestone with the CE Mark approval of its cutting-edge Mosaic 3D™ technology. This approval under the European Medical Device Regulation (MDR) signifies a major leap forward in the platform's global expansion, showcasing its advanced fractional resurfacing capabilities.

Overview of Mosaic 3D™

Mosaic 3D™ is touted as the next generation in non-ablative fractional laser technologies. It promises increased energy delivery and broader treatment coverage while maintaining a focus on patient safety and comfort. Thanks to its innovative 3D Controlled Chaos Technology™ (CCT), the system ensures an optimal distribution of energy and minimizes thermal risk, thus enhancing treatment effectiveness without discomfort.

One of the standout features of Mosaic 3D™ is its integrated cooling system. This system is specifically designed to treat sensitive areas around the eyes and mouth, employing air-cooling mechanisms that work through cold-compression sapphire tips. This dual approach not only reduces discomfort but also improves treatment outcomes, leading to revitalized and glowing skin.

Clinical Validation and Feedback

The medical community has embraced Mosaic 3D™; it is currently being explored in clinical practices and studies led by renowned experts worldwide, including Dr. Guy Erlich from Israel, Professor Merete Haedersdal from Denmark, and Dr. Tatiana Kuznechenkova from the UAE. Dr. Erlich mentioned, "Mosaic 3D™ sets a new standard in fractional resurfacing, showcasing excellent tissue responses and versatile treatment options."

Professor Haedersdal highlighted the significance of imaging analyses in understanding laser-tissue interactions with Mosaic 3D™, paving the way for optimized treatment protocols. Dr. Kuznechenkova reported promising results after using Mosaic 3D™, emphasizing its ability to tailor treatments for individual patient needs, leading to heightened satisfaction and superior clinical results.

Launch Events and Future Plans

Mosaic 3D™ was first unveiled during the Cynosure Lutronic Science and Laser Symposium 2025 in Faro, where it received overwhelming enthusiasm from attending industry professionals. With the recent EU MDR endorsement, the technology is set to play a pivotal role at the upcoming IMCAS World Congress 2026. Cynosure Lutronic is expected to host a scientific symposium featuring Dr. Guy Erlich and Professor Merete Haedersdal, focusing on real-world applications and clinical data related to Mosaic 3D™.

The symposium, titled "Redefining Non-Ablative Fractional Lasers (NAFL)," will take place on January 30th at 3:45 PM in Room 351 on Level 3, catering to healthcare professionals keen on leveraging new insights and data.

Conclusion

Cynosure Lutronic's commitment to advancing innovation in aesthetic technology is clear with the introduction of Mosaic 3D™. With its approval and the momentum it has gained globally, it stands poised to redefine treatments and elevate patient outcomes within the dermatology and aesthetic surgery sectors. With over 30 years of experience in energy-based devices, Cynosure Lutronic continues to set the bar high for non-invasive and minimally invasive treatments across various applications, underscoring its leadership in this competitive landscape.